Lyell Immunopharma (NASDAQ:LYEL) Stock Price Expected to Rise, HC Wainwright Analyst Says
Lyell Immunopharma (NASDAQ:LYEL – Get Free Report) had its price target boosted by research analysts at HC Wainwright to $10.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. HC Wainwright’s price target would suggest a potential upside of 7.64% from the […]
